TruWealth Advisors LLC Purchases New Position in Lam Research Corporation $LRCX

TruWealth Advisors LLC acquired a new position in shares of Lam Research Corporation (NASDAQ:LRCX) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm acquired 117,446 shares of the semiconductor company’s stock, valued at approximately $15,726,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Norges Bank purchased a new stake in Lam Research in the second quarter worth about $1,894,585,000. JPMorgan Chase & Co. raised its stake in Lam Research by 14.4% in the second quarter. JPMorgan Chase & Co. now owns 40,622,437 shares of the semiconductor company’s stock worth $3,954,188,000 after buying an additional 5,102,589 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in Lam Research by 99.7% during the first quarter. Price T Rowe Associates Inc. MD now owns 5,739,221 shares of the semiconductor company’s stock worth $417,242,000 after buying an additional 2,864,863 shares during the period. Nordea Investment Management AB boosted its position in Lam Research by 34.1% during the 2nd quarter. Nordea Investment Management AB now owns 10,594,574 shares of the semiconductor company’s stock valued at $1,029,210,000 after acquiring an additional 2,692,189 shares in the last quarter. Finally, Artisan Partners Limited Partnership lifted its stake in shares of Lam Research by 35.4% during the 2nd quarter. Artisan Partners Limited Partnership now owns 9,849,868 shares of the semiconductor company’s stock worth $958,786,000 after purchasing an additional 2,575,456 shares during the last quarter. Institutional investors own 84.61% of the company’s stock.

Lam Research Trading Up 2.4%

NASDAQ:LRCX opened at $164.30 on Tuesday. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The firm has a fifty day simple moving average of $152.83 and a 200-day simple moving average of $121.06. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $169.69. The company has a market capitalization of $206.37 billion, a P/E ratio of 36.19, a PEG ratio of 1.65 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm’s revenue was up 27.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, equities research analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be issued a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a yield of 0.6%. Lam Research’s payout ratio is presently 22.91%.

Insider Buying and Selling

In other news, Director Bethany Mayer sold 1,298 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the sale, the director owned 1,652 shares of the company’s stock, valued at $264,303.48. This trade represents a 44.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction on Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the transaction, the chief financial officer owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. This represents a 3.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 102,608 shares of company stock worth $14,916,496. 0.31% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Wall Street Zen lowered Lam Research from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Hsbc Global Res raised shares of Lam Research to a “hold” rating in a research report on Tuesday, September 30th. Sanford C. Bernstein increased their target price on shares of Lam Research from $170.00 to $175.00 and gave the company an “outperform” rating in a research report on Friday, November 21st. New Street Research raised their target price on shares of Lam Research from $105.00 to $140.00 and gave the company a “neutral” rating in a research note on Thursday, October 23rd. Finally, Oppenheimer set a $200.00 price target on Lam Research and gave the stock an “outperform” rating in a research report on Thursday, October 23rd. Twenty-six research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $156.21.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.